Finanzwire Finanzwire
Basculer en Français
10651 Companies
226551 Keywords
155036 Articles
119948 Press releases
Headlines Articles Press releases POP Biotechnologies, Inc. Remove
  1. Home
  2. Companies
  3. POP Biotechnologies, Inc.
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 09/27/2024 at 20:05, 1 year 9 months ago

    POP Biotechnologies Announces Positive Interim Results for COVID-19 Vaccine Trial

    COVID-19 Vaccine Phase 3 Trial Immunogenicity EuCorVac-19 POP BIO SNAP
  • PRESS RELEASE

    published on 09/27/2024 at 20:00, 1 year 9 months ago

    POP Biotechnologies Announces Phase 3 Trial Interim Results Published for COVID-19 Vaccine Based on POP BIO SNAP(TM)

    POP Biotechnologies and EuBiologics announce positive findings of ECV-19 COVID-19 vaccine in Phase 3 trial in the Philippines, demonstrating safety, immunogenicity, and potential against Omicron variant
    COVID-19 Vaccine Phase 3 Trial POP Biotechnologies EuBiologics ECV-19
    Logo of POP Biotechnologies, Inc.
  • PRESS RELEASE

    published on 07/14/2023 at 18:00, 2 years 11 months ago

    POP Biotechnologies and EuBiologics' EuCorVac-19 COVID-19 Vaccine Hits Target in Phase 3 Trial

    Logo of POP Biotechnologies, Inc.
Accesswire
  • Published on 06/27/2026 at 16:50, 1 day 4 hours ago

    Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security

  • Published on 06/27/2026 at 01:40, 1 day 19 hours ago

    Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting

  • Published on 06/27/2026 at 00:00, 1 day 20 hours ago

    Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010

  • Published on 06/26/2026 at 23:00, 1 day 21 hours ago

    Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting

  • Published on 06/26/2026 at 22:50, 1 day 22 hours ago

    Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada

View all ACCESSWIRE
EQS Group
  • Published on 06/28/2026 at 20:00, 58 minutes ago

    CPI Property Group – Successful Hybrid Tender and New Issue

  • Published on 06/28/2026 at 19:45, 1 hour 13 minutes ago

    PSP Swiss Property, Invitation Conference Call

  • Published on 06/28/2026 at 17:26, 3 hours 32 minutes ago

    EQS-Adhoc: Correction of a release from 24/06/2026, 20:54 CET/CEST - Branicks Group AG sets out timetable for the publication of its 2025 annual and consolidated financial statements

  • Published on 06/27/2026 at 00:05, 1 day 20 hours ago

    EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss

  • Published on 06/27/2026 at 00:04, 1 day 20 hours ago

    Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering

View all EQS
Les Echos
  • Published on 06/26/2026 at 17:45, 2 days 3 hours ago

    Combined General Meeting, June 25, 2026

  • Published on 06/26/2026 at 14:44, 2 days 6 hours ago

    Safran information

  • Published on 06/26/2026 at 07:00, 2 days 13 hours ago

    Advancing Women’s Health with Rapid Diagnostics: bioMérieux files a Dual 510(k) /CLIA Waiver application to the FDA for the BIOFIRE® SPOTFIRE® Vaginitis Panel

  • Published on 06/25/2026 at 17:50, 3 days 3 hours ago

    DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS

  • Published on 06/25/2026 at 07:30, 3 days 13 hours ago

    Gimv signs an agreement to acquire Groupe Cap Vert, France’s leading multi-specialist provider of tree and vegetation critical management services, from Ambienta.

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy